0Q6H Stock Chart & Stats
kr1.40
kr0.00(0.00%)
At close: 4:00 PM EDT
kr1.40
kr0.00(0.00%)
Day’s Range― - ―
52-Week Rangekr1.28 - kr1.90
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
kr746.80M
Enterprise Valuekr797.22
Total Cash (Recent Filing)kr71.95M
Total Debt (Recent Filing)kr236.19M
Price to Earnings (P/E)―
Beta0.60
Next Earnings
Nov 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.31
Shares Outstanding506,235,630
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Hofseth Biocare ASA News
0Q6H FAQ
What was Hofseth Biocare ASA’s price range in the past 12 months?
Hofseth Biocare ASA lowest share price was kr1.27 and its highest was kr1.90 in the past 12 months.
What is Hofseth Biocare ASA’s market cap?
Hofseth Biocare ASA’s market cap is kr746.80M.
When is Hofseth Biocare ASA’s upcoming earnings report date?
Hofseth Biocare ASA’s upcoming earnings report date is Nov 06, 2026 which is in 66 days.
How were Hofseth Biocare ASA’s earnings last quarter?
Hofseth Biocare ASA released its earnings results on Jun 30, 2026. The company reported -kr0.057 earnings per share for the quarter.
Is Hofseth Biocare ASA overvalued?
According to Wall Street analysts Hofseth Biocare ASA’s price is currently Overvalued.
Does Hofseth Biocare ASA pay dividends?
Hofseth Biocare ASA does not currently pay dividends.
What is Hofseth Biocare ASA’s EPS estimate?
Hofseth Biocare ASA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hofseth Biocare ASA have?
Hofseth Biocare ASA has 506,235,630 shares outstanding.
What happened to Hofseth Biocare ASA’s price movement after its last earnings report?
Hofseth Biocare ASA reported an EPS of -kr0.057 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Hofseth Biocare ASA?
Currently, no hedge funds are holding shares in GB:0Q6H
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Hofseth Biocare ASA
Hofseth BioCare ASA, an international firm based in Norway, specializes in developing and supplying premium biomarine ingredients for both human and animal health. The company's product portfolio features various specialized offerings, including Brilliant salmon oil and OmeGo salmon oil, which promotes healthy cholesterol levels and supports cardiovascular well-being. ProGo, a salmon protein hydrolysate, serves as a rapidly assimilated protein supplement. For skeletal and joint health, Hofseth offers CalGo, a marine calcium powder. CollaGo, a collagen peptide powder, is designed to improve the appearance of hair, skin, and nails. Additionally, PetGo provides a non-soluble protein formulation. Distribution of these products is managed through a multi-channel approach, utilizing a network of distributors, agents, and its dedicated internal sales team. Hofseth BioCare also holds a significant research collaboration with Stanford University School of Medicine, focusing on pre-clinical and clinical studies related to conditions such as necrotizing enterocolitis and irritable bowel syndrome. Established in 2000, the company's main operations are based in Ålesund, Norway.
Technical Analysis
Hofseth Biocare ASA
―
―
Kali
―
Nutriband
―
BioNTech SE
―
RegenXBio
―
Fate Therapeutics
―